Entamoeba dispar does not produce the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica

Parasite Immunology

Volumn 25, Issue 2, 2003, Pages 99-101

  García, R Silva ^a   Rosillo, G Rico ^a   Cantellano, M Espinosa ^a   Castanon G ^b   Scherer, J Giménez ^b   Kretschmer, Robert ^a,c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c U de Invest Medica en Inmunologia   (Mexico)

Author keywords

Entamobea dispar; Entamoeba histolytica; Monocytes

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; MONOCYTE LOCOMOTION INHIBITORY FACTOR; PENTAPEPTIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CULTURE MEDIUM; DELAYED HYPERSENSITIVITY; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; EOSINOPHIL; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; SUPERNATANT;

ANIMALS; CHROMATOGRAPHY; CULTURE MEDIA; ENTAMOEBA; ENTAMOEBA HISTOLYTICA; GUINEA PIGS; OLIGOPEPTIDES; PROTOZOAN PROTEINS; SPECIES SPECIFICITY;

ENTAMOEBA; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA;

EID: 0038539248     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2003.00608.x     Document Type: Article

References (13)

1. Diamond LS & Clark CG. A redescription of Entamoeba histolytica, (Schaudinn, 1903) separating it from Entamoeba dispar, (Brump 1925). J Euk Microbiol 1993; 40: 340-344.
2. Clark CG. Entamoeba dispar, an organism reborn. Trans Roy Soc Trop Med Hyg 1998; 92: 361-364.
3. Jackson TFHG. Entamoeba histolytica and Entamoeba dispar are distinct species; clinical, epidemiological and serological evidence. Int J Parasitol 1998; 28: 181-186.
4. Kretschmer R, Rico G & Giménez JA. A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica. Mol Bioch Parasitol 2001; 112: 201-209.
5. Rico G, Díaz O, Giménez JA & Kretschmer R. Effect of the Monocyte Locomotion Inhibitory Factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes. Arch Med Res 1992; 23 (2): 157-159.
6. Rico G, Leandro E, Rojas S, Giménez JA & Kretschmer R. The effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon nitric oxide production by human leucocytes. Arch Med Res 2000; 31: S90-S91.
7. Rico G, Arellano J & Kretschmer R. The human monocyte locomotion inhibitory factor produced by Entamoeba histolytica does not inhibit the locomotion of human eosinophils. Paras Res 1998; 84: 522-523.
8. Kretschmer R, Collado L, Pacheco G et al. Inhibition of monocyte locomotion by products of axenically grown Entamoeba histolytica. Parasite Immunol 1985; 7: 527-543.
9. National Center For Biotechnology Information (NCBI) www:ncbi.nlm.nih.gov.
10. Bradford MA. A rapid and sensitive method for the quantitation of protein utilizing the principle of protein-dye binding. Ann Bioch 1976; 72: 248-254.
11. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Invest 1968; 21: 77-109.
12. Giménez-Scherer JA, Rico G, Fernández J & Kretschmer RR. Inhibition of contact cutaneous delayed hypersensitivity reactions to DNBC in guinea pigs by the monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica. Arch Med Res 1997; 28: S237-S38.
13. Siegel S & Castellan NJ. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York; 1956.